344 related articles for article (PubMed ID: 15858026)
1. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
Jana NK; Gray LR; Shugars DC
J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
[TBL] [Abstract][Full Text] [Related]
2. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
[TBL] [Abstract][Full Text] [Related]
3. Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells.
Si-Tahar M; Merlin D; Sitaraman S; Madara JL
Gastroenterology; 2000 Jun; 118(6):1061-71. PubMed ID: 10833481
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
[TBL] [Abstract][Full Text] [Related]
5. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
6. Endogenous mucosal antiviral factors of the oral cavity.
Shugars DC
J Infect Dis; 1999 May; 179 Suppl 3():S431-5. PubMed ID: 10099113
[TBL] [Abstract][Full Text] [Related]
7. Mitosis increases levels of secretory leukocyte protease inhibitor in keratinocytes.
Lai JY; Borson ND; Strausbauch MA; Pittelkow MR
Biochem Biophys Res Commun; 2004 Apr; 316(2):407-10. PubMed ID: 15020232
[TBL] [Abstract][Full Text] [Related]
8. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.
Baqui AA; Meiller TF; Falkler WA
Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568
[TBL] [Abstract][Full Text] [Related]
9. Short communication: Increased expression of secretory leukocyte protease inhibitor in oral mucosa of Colombian HIV type 1-exposed seronegative individuals.
Taborda N; Zapata-Builes W; Montoya C; Rugeles MT
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1059-62. PubMed ID: 22149181
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor.
Turpin JA; Schaeffer CA; Bu M; Graham L; Buckheit RW; Clanton D; Rice WG
Antiviral Res; 1996 Mar; 29(2-3):269-77. PubMed ID: 8739605
[TBL] [Abstract][Full Text] [Related]
11. Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse.
Soboll G; Schaefer TM; Wira CR
Am J Reprod Immunol; 2006 Jun; 55(6):434-46. PubMed ID: 16674601
[TBL] [Abstract][Full Text] [Related]
12. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.
Chattopadhyay A; Gray LR; Patton LL; Caplan DJ; Slade GD; Tien HC; Shugars DC
Infect Immun; 2004 Apr; 72(4):1956-63. PubMed ID: 15039315
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.
McNeely TB; Shugars DC; Rosendahl M; Tucker C; Eisenberg SP; Wahl SM
Blood; 1997 Aug; 90(3):1141-9. PubMed ID: 9242546
[TBL] [Abstract][Full Text] [Related]
14. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 is a potent inhibitor of secretory leukoprotease inhibitor expression in a bronchial epithelial cell line. Munich Lung Transplant Group.
Jaumann F; Elssner A; Mazur G; Dobmann S; Vogelmeier C
Eur Respir J; 2000 Jun; 15(6):1052-7. PubMed ID: 10885424
[TBL] [Abstract][Full Text] [Related]
16. Aberrant mucosal wound repair in the absence of secretory leukocyte protease inhibitor.
Angelov N; Moutsopoulos N; Jeong MJ; Nares S; Ashcroft G; Wahl SM
Thromb Haemost; 2004 Aug; 92(2):288-97. PubMed ID: 15269824
[TBL] [Abstract][Full Text] [Related]
17. Oral innate immunity in HIV infection in HAART era.
Nittayananta W; Tao R; Jiang L; Peng Y; Huang Y
J Oral Pathol Med; 2016 Jan; 45(1):3-8. PubMed ID: 25639844
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
Skott P; Lucht E; Ehnlund M; Björling E
Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
[TBL] [Abstract][Full Text] [Related]
19. Endogenous salivary inhibitors of human immunodeficiency virus.
Shugars DC; Alexander AL; Fu K; Freel SA
Arch Oral Biol; 1999 Jun; 44(6):445-53. PubMed ID: 10401522
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of secretory leukocyte protease inhibitor expression in gastric mucosa is a general phenomenon in Helicobacter pylori-related gastroduodenal diseases.
Wex T; Sokic-Milutinovic A; Todorovic V; Bjelovic M; Milosavljevic T; Pesko P; Malfertheiner P
Dig Dis; 2004; 22(4):390-5. PubMed ID: 15812165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
